Structural Biology of Polyether Antibiotic Biosynthesis
Structural Biology of Polyether Antibiotic Biosynthesis
批准号:
10261453
负责人:
Chu-Young Kim
金额:
$15.1万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-15 至 2025-08-31
关键词:
Acyl Carrier ProteinAcyltransferaseAnabolismAnti-Bacterial AgentsAntibioticsAntifungal AgentsBacteriaBiochemicalBiogenesisBiological ModelsChemicalsComplexCrystallizationCyclic EthersCyclizationDevelopmentDockingEngineeringEnsureEnzymesEpoxide hydrolaseEpoxy CompoundsFamilyFlavinsFoundationsFutureGene ClusterGoalsInvestigationLaboratoriesMixed Function OxygenasesMolecularMolecular ConformationNatural ProductsNatureOrganismPathway interactionsPharmaceutical ChemistryPharmaceutical PreparationsPolyenesProductionPropertyReactionResearchSchemeSolidStreptomycesStructureSubgroupTechniquesTestingTherapeuticTimeVertebral columnWorkYeastsanti-cancerbasedimerdrug developmentenzyme biosynthesisnovelnovel therapeuticspolyketide synthaseprogramsprotein protein interactionsealstructural biology
中文摘要
我们研究计划的首要目标是阐明自然界如何产生聚醚。
天然产品。聚醚是聚酮类天然产物的一个子族,作为一类,它们
具有广泛的有用活性,包括抗菌、抗真菌和抗癌
属性。然而,聚醚药物的开发受到我们无法快速和
药物化学和药物用天然聚醚及其衍生物的高效合成
优化研究。这是由于天然聚醚的结构异常复杂。一个
解决这一问题的有吸引力的方案是利用工程合成复杂的聚醚
实验室友好的生物,如细菌或酵母菌。这种方法预计将使
无数新的聚醚可用于药物研究。为了创造一个稳健可靠的
聚醚生物生产平台,首先要做到精细化全面
了解聚醚是如何在生物体内产生的。100多种不同的
到目前为止,已发现聚醚天然产物,并对已知聚醚进行了检验
生物合成基因簇表明,所有的聚醚都是通过共同的三个阶段产生的。
生物合成方案。阶段1:用模块化聚酮构建聚酮骨架
合成酶。阶段2:用单加氧酶立体选择性地环氧化多烯中间体。
阶段3:一个或多个环氧化物水解酶形成标志性环醚基团。这个
这一计划的普遍性确保了对任何一种特定聚醚的调查
生物合成途径及其相关的酶将导致对如何
大自然会产生聚醚。在这个项目中,我们将研究从生物合成酶
拉萨洛菌素A的生物合成途径。拉沙洛西德A的生物合成
路径是研究自然界如何产生聚醚的一个很好的模型系统,因为它
只由九种酶组成,但它拥有所有标志性的化学转化
聚醚生物合成。
英文摘要
The overarching goal of our research program is to elucidate how nature produces polyether
natural products. Polyethers are a subgroup of polyketide natural products and, as a class, they
possess a wide range of useful activities, including antibacterial, antifungal, and anticancer
properties. However, polyether drug development is hampered by our inability to quickly and
efficiently synthesize natural polyethers and their derivatives for medicinal chemistry and drug
optimization studies. This is due to the unusually complex structure of natural polyethers. An
attractive solution to this problem is to biosynthesize complex polyethers using engineered
laboratory-friendly organisms such as bacteria or yeast. This approach is expected to make
countless new polyethers accessible for drug research. In order to create a robust and reliable
polyether bioproduction platform, we must first achieve a detailed and comprehensive
understanding of how polyethers are produced in living organisms. More than 100 different
polyether natural products have been discovered so far, and examination of known polyether
biosynthetic gene clusters show that all polyethers are generated via a common three-stage
biosynthetic scheme. Stage 1: construction of the polyketide backbone by modular polyketide
synthases. Stage 2: stereoselective epoxidation of the polyene intermediate by a monooxygenase.
Stage 3: formation of the hallmark cyclic ether groups by one or more epoxide hydrolases. The
universal nature of this scheme ensures that investigation of any one particular polyether
biosynthesis pathway and its associated enzymes will lead to a general understanding of how
nature generates polyethers. In this project, we will study the biosynthetic enzymes from the
lasalocid A biosynthesis pathway from Streptomyces lasaliensis. Lasalocid A biosynthesis
pathway is an excellent model system for studying how nature produces polyethers because it
consists of just nine enzymes, yet it possesses all the hallmark chemical transformations of
polyether biosynthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural biology of polyether antibiotic biosynthesis
-
批准号:10912964
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2020
-
负责人:Chu-Young Kim
-
依托单位:
Selective targeting of human alkaline phosphatase isozymes
-
批准号:10359823
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2020
-
负责人:Chu-Young Kim
-
依托单位:
Selective targeting of human alkaline phosphatase isozymes
-
批准号:10117265
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2020
-
负责人:Chu-Young Kim
-
依托单位:
Structural Biology of Polyether Antibiotic Biosynthesis
-
批准号:10036330
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2020
-
负责人:Chu-Young Kim
-
依托单位:
海外基金